全球牛市場規模、佔有率和成長分析：按最終用戶和應用分類 - 產業預測（2024-2031）

Global Fetal Bovine Serum Market Size, Share, Growth Analysis, By End-user(Pharmaceutical & Biotechnology Companies, Contract & Academic Research Organizations), By Application(Drug Discovery, In-vitro Fertilization) - Industry Forecast 2024-2031

出版日期: 2024年03月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球牛市場規模將從2023年的17.9億美元增加至2022年的15.7億美元，在預測期內（2024-2031年）複合年成長率為14.1%，預計將成長至51.5億美元到2031年。

全球牛（FBS）市場的主要目標是滿足生物醫學研究和開發中對優質細胞培養補充品不斷成長的需求。有幾個因素促進了這個市場的擴張。首先，生物技術和製藥領域研發活動投資的增加正在推動對胎牛血清的需求。其次，慢性病的盛行率不斷上升以及對有效治療解決方案的需求需要進行廣泛的細胞研究，從而推動了對胎牛血清的需求。然而，全球牛市場正面臨各種挑戰。關鍵挑戰之一是胎牛血清批次的品質和成分的可變性，這可能會影響研究結果的再現性和可靠性。儘管如此，這個市場仍然存在著成長和創新的機會。作為胎牛血清替代品的無血清培養基和化學成分確定的培養基配方的出現，為市場相關人員提供了滿足對不含動物成分的細胞培養解決方案的需求的途徑。全球牛市場在支持生物醫學研究和細胞培養應用方面發揮著至關重要的作用。儘管面臨道德問題、監管限制和品質差異，但市場提供了創新和探索替代解決方案的機會。對細胞研究、再生醫學和生技藥品的需求不斷成長正在推動市場發展，凸顯了高品質胎牛血清在科學突破和治療方法進展中的重要性。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Thermo Fisher Scientific Inc.（US）
Merck KGaA（Germany）
GE Healthcare（US）
Tissue Culture Biologicals（US）
HiMedia Laboratories Pvt. Ltd.（India）
Atlanta Biologicals Inc.（US）
Sigma-Aldrich Corporation（US）
Rocky Mountain Biologicals（US）
PAN-Biotech GmbH（Germany）
Bovogen Biologicals Pty Ltd.（Australia）
Biowest SAS（France）
Biological Industries Israel Beit Haemek Ltd.（Israel）
Corning Incorporated（US）
Sera Laboratories International Ltd.（UK）
Caisson Laboratories Inc.（US）
Hyclone Laboratories Inc.（US）
Lanzhou Minhai Biotechnology Co., Ltd.（China）
Moregate BioTech（UK）
Gemini Bio-Products（US）
Lampire Biological Laboratories（US）

簡介目錄

Product Code: SQMIG35I2208

Global Fetal Bovine Serum Market size was valued at USD 1.57 billion in 2022 and is poised to grow from USD 1.79 billion in 2023 to USD 5.15 billion by 2031, by rising at a CAGR of 14.1% during the forecast period (2024-2031).

The primary objective of the global fetal bovine serum (FBS) market is to address the rising need for premium-quality cell culture supplements in biomedical research and development. Several factors contribute to the expansion of this market. Firstly, the growing investments in research and development activities across the biotechnology and pharmaceutical sectors drive the demand for FBS. Secondly, the increasing prevalence of chronic diseases and the imperative for effective therapeutic solutions necessitate extensive cell-based research, thereby boosting the demand for FBS. However, the global fetal bovine serum market encounters various challenges. One significant challenge is the variability in the quality and composition of FBS batches, which can impact the reproducibility and reliability of research outcomes. Nonetheless, the market presents opportunities for growth and innovation. The emergence of serum-free and chemically defined media formulations as substitutes to FBS creates avenues for market players to cater to the demand for animal component-free cell culture solutions. The global fetal bovine serum market holds a pivotal role in supporting biomedical research and cell culture applications. Despite facing ethical concerns, regulatory restrictions, and quality variability, the market offers opportunities for innovation and the exploration of alternative solutions. The escalating demand for cell-based research, regenerative medicine, and biologics drives the market, underscoring the significance of high-quality FBS in advancing scientific breakthroughs and therapeutic advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the global fetal bovine serum market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fetal Bovine Serum Market Segmental Analysis

The global fetal bovine serum market is segmented based on end-user, application, and region. By end-user, the market is segmented into pharmaceutical & biotechnology companies, contract & academic research organizations. By application, the market is segmented into drug discovery, in-vitro fertilization, vaccine production, cell-based research, diagnostics, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Fetal Bovine Serum Market

The biopharmaceutical industry experienced substantial growth, prioritizing the development of innovative therapeutic solutions. Fetal bovine serum (FBS), playing a crucial role in cell culture-based research, saw widespread use in drug discovery, preclinical testing, and biologics production. The heightened investment in biopharmaceutical research and development activities propelled the demand for FBS.

Restraints in the Global Fetal Bovine Serum Market

The utilization of animal-derived products, such as FBS, raised ethical concerns among certain researchers and regulatory bodies. The imperative to minimize or eradicate animal-derived components in cell culture systems prompted the investigation of alternative serum-free and defined media formulations. The presence of these alternatives presented a challenge to the expansion of the FBS market.

Market Trends of the Global Fetal Bovine Serum Market

The industry witnessed a trend towards the creation and adoption of animal component-free culture systems. Researchers and manufacturers aimed to decrease reliance on FBS by transitioning to defined media formulations devoid of animal-derived components. This trend aimed to tackle ethical concerns, improve experimental reproducibility, and streamline regulatory compliance.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Fetal Bovine Serum Market by End-user

Market Overview
Pharmaceutical & Biotechnology Companies
Contract & Academic Research Organizations

Global Fetal Bovine Serum Market by Application

Market Overview
Drug Discovery
In-vitro Fertilization
Vaccine Production
Cell-based Research
Diagnostics
and Others

Global Fetal Bovine Serum Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissue Culture Biologicals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atlanta Biologicals Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rocky Mountain Biologicals (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PAN-Biotech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bovogen Biologicals Pty Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biowest SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biological Industries Israel Beit Haemek Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sera Laboratories International Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caisson Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hyclone Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lanzhou Minhai Biotechnology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moregate BioTech (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gemini Bio-Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lampire Biological Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments